Link between tumor necrosis factor inhibitors and onset of uveitis: Comment on the article by Lim et al.

Arthritis and Rheumatism

Volumn 58, Issue 5, 2008, Pages 1554-

  Sheane, Barry J ^a   Howard, Donough ^a   Doran, Michele F ^a   Cunnane, Gaye ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

DISEASE ASSOCIATION; DISEASE REGISTRY; DRUG EFFECT; HUMAN; LETTER; PRIORITY JOURNAL; RHEUMATIC DISEASE; UVEITIS;

ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOGLOBULIN G; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS;

EID: 43949135196     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23441     Document Type: Letter

References (4)

1. Lim LL, Fraunfelder FW, Rosenbaum JT. Do tumor necrosis factor inhibitors cause uveitis? A registry-based study. Arthritis Rheum 2007;56:3248-52.
2. Smith JR, Levinson RD, Holland GN, Jabs DA, Robinson MR, Whitcup SM, et al. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum 2001;45:252-7.
3. Jarrett SJ, Cunnane G, Conaghan PG, Bingham SJ, Buch MH, Quinn MA, et al. Anti-tumor necrosis factor-α therapy-induced vasculitis: case series. J Rheumatol 2003;30:2287-91.
4. Lin J, Ziring D, Desai S, Kim S, Wong M, Korin Y, et al. TNFα blockade in human diseases: an overview of efficacy and safety. Clin Immunol 2008;126:121-36.